Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Brought to you by

Solvay agrees to acquire Fournier

04 Apr 2005

Executive Summary

To strengthen its cardiology business and research pipeline, Solvay has signed a memorandum of understanding to buy Fournier Pharma for €1.3bn ($2.1bn) in cash. Both have portfolios of drugs to treat cardiovascular, gastroenterological, psychiatric, and gynecological conditions.
Deal Industry
  • Pharmaceuticals
Deal Status
  • Preliminary
Deal Type
  • Acquisition
    • Full Acquisition
    • Payment Includes Cash

Related Companies

UsernamePublicRestriction

Register

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By